Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy HealthEquity stock | $83.12
Learn how to easily invest in HealthEquity stock.
HealthEquity, Inc is a health information services business based in the US. HealthEquity shares (HQY) are listed on the NASDAQ and all prices are listed in US Dollars. HealthEquity employs 3,001 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in HealthEquity
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – HQY – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
HealthEquity stock price (NASDAQ: HQY)Use our graph to track the performance of HQY stocks over time.
HealthEquity shares at a glance
|Latest market close||$83.12|
|52-week range||$45.82 - $93.32|
|50-day moving average||$78.65|
|200-day moving average||$77.46|
|Wall St. target price||$89.30|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.06|
Buy HealthEquity shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy HealthEquity stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
HealthEquity price performance over time
|1 week (2021-07-24)||N/A|
|1 month (2021-07-02)||0.57%|
|3 months (2021-05-04)||11.86%|
|6 months (2021-01-31)||N/A|
|1 year (2020-07-31)||N/A|
|2 years (2019-07-31)||N/A|
|3 years (2018-07-31)||N/A|
|5 years (2016-07-31)||N/A|
Is HealthEquity under- or over-valued?
Valuing HealthEquity stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of HealthEquity's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
HealthEquity's P/E ratio
HealthEquity's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1323x. In other words, HealthEquity shares trade at around 1323x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
HealthEquity's PEG ratio
HealthEquity's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.4267. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into HealthEquity's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
HealthEquity's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $185.4 million.
The EBITDA is a measure of a HealthEquity's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$727.8 million|
|Operating margin TTM||8.96%|
|Gross profit TTM||$415.3 million|
|Return on assets TTM||1.42%|
|Return on equity TTM||0.3%|
|Market capitalisation||$6.3 billion|
TTM: trailing 12 months
Shorting HealthEquity shares
There are currently 4.0 million HealthEquity shares held short by investors – that's known as HealthEquity's "short interest". This figure is 1.3% up from 4.0 million last month.
There are a few different ways that this level of interest in shorting HealthEquity shares can be evaluated.
HealthEquity's "short interest ratio" (SIR)
HealthEquity's "short interest ratio" (SIR) is the quantity of HealthEquity shares currently shorted divided by the average quantity of HealthEquity shares traded daily (recently around 441734.64480874). HealthEquity's SIR currently stands at 9.15. In other words for every 100,000 HealthEquity shares traded daily on the market, roughly 9150 shares are currently held short.
However HealthEquity's short interest can also be evaluated against the total number of HealthEquity shares, or, against the total number of tradable HealthEquity shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case HealthEquity's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 HealthEquity shares in existence, roughly 50 shares are currently held short) or 0.0493% of the tradable shares (for every 100,000 tradable HealthEquity shares, roughly 49 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against HealthEquity.
Find out more about how you can short HealthEquity stock.
HealthEquity share dividends
We're not expecting HealthEquity to pay a dividend over the next 12 months.
HealthEquity share price volatility
Over the last 12 months, HealthEquity's shares have ranged in value from as little as $45.82 up to $93.32. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while HealthEquity's is 1.3678. This would suggest that HealthEquity's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc.
Stocks similar to HealthEquity
HealthEquity in the news
Kornitzer Capital Management Inc Buys DoubleVerify Holdings Inc, Genius Sports, Builders FirstSource Inc, Sells CyrusOne Inc, , Kansas City Southern
HealthEquity (HQY) Sees Hammer Chart Pattern: Time to Buy?
Were Hedge Funds Right About Selling Healthequity Inc (HQY)?
Frequently asked questionsWhat percentage of HealthEquity is owned by insiders or institutions?
Currently 1.833% of HealthEquity shares are held by insiders and 100.26% by institutions. How many people work for HealthEquity?
Latest data suggests 3,001 work at HealthEquity. When does the fiscal year end for HealthEquity?
HealthEquity's fiscal year ends in January. Where is HealthEquity based?
HealthEquity's address is: 15 West Scenic Pointe Drive, Draper, UT, United States, 84020 What is HealthEquity's ISIN number?
HealthEquity's international securities identification number is: US42226A1079 What is HealthEquity's CUSIP number?
HealthEquity's Committee on Uniform Securities Identification Procedures number is: 42226A107
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert